U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07215923) titled 'A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers' on Oct. 07.
Brief Summary: This study is a first-in-human clinical trial of drug ATI-1013, in healthy adult cigarette smokers. The main questions it aims to answer are to learn about the safety of drug ATI-1013, how long drug ATI-1013 remains within the body, does drug ATI-1013 trigger an immune response, and the effects of drug ATI-1013 on nicotine levels within the body.
The clinical trial will compare drug ATI-1013 to a placebo (a look-alike substance that contains no drug) to see if drug ATI-1013 has comparable safety.
Participants will have a S...